Indian stock alert

INDIA

CLOSING UPDATE: Sun Pharmaceutical Industries decreases further 0.7% - underperforming 82% of stocks 18 January 2018 17:24 IST

NEWS BITES - BRIC

This is an end of day Alert, produced after today's Indian market close. It concludes the BSS News Bites intra-day Alert series (summaries below).

Sun Pharmaceutical Industries, India's largest pharmaceuticals company by market capitalisation, has decreased Rs7.05 (or 1.2%) today to trade at Rs576.70 and has underperformed 82% of the market in the past one year. The present value of Rs1,000 invested one year ago is Rs899 [vs Rs1,294 for the BSE SENSEX Index], including a capital loss of Rs107 and dividend reinvested of Rs6. Compared with the BSE SENSEX Index which rose 178.5 points (or 0.5%) in the day, this represented a relative price change of -1.7%.

Technical indicators complementing today's significant downtrend:

+ The price decreased 1.9% in the last week.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Overvaluation:

+ Price/Sales of 4.4 [3.7]

Other Bearish Signals include:

+ Tobin's Q Ratio is 2.3. Compared with the rest of the market the stock is overvalued and ranks in the bottom quartile of stocks by value of Q Ratio.

Note

Sun Pharmaceutical Industries today is at a discount of 20.4% to the 12-month high of Rs724.18 on 14 Mar, 2017. It is at a premium of 34.2% to the 12-month low of Rs429.81 on 14 Aug, 2017.

Bullish Signals:

The positive 11.54 MACD (Moving Average Convergence Divergence) indicator suggests a bullish signal.

Total Liabilities/EBITDA of 2.4 is comfortably below the Joseph Piotroski benchmark of <5.

Net profit margin has averaged 21.8% in the last 3 years. This is considered superior and suggests a high margin of safety.

As per the Du Pont analysis, Return on Equity of 19.1% is better than sector average of 13.3%.

Fundamental measures by comparison with the sector average [in brackets] indicate:

Undervaluation:

Price/Earnings of 19.9 [29.5]

Price/Earnings/Growth of 0.83 [4.8]

Price to Book of 5.3 [5.9]

Return on Equity 19.1% [13.3%]

Return on Assets 12.8% [7.2%]

Return on Capital Employed 20.8% [15.1%]

Year-on-Year Earnings Growth of 48% [6.1%]

TODAY'S ALERT

Afternoon Alert: Sun Pharmaceutical Industries decreases 0.5% - underperforming 87% of stocks

18 January 2018 13:00 IST

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) has decreased Rs3.20 (or 0.5%) today to trade at Rs580.55 and has underperformed 87% of the market in the past one year. The present value of Rs1,000 invested one year ago is Rs905 [vs Rs1,302 for the BSE SENSEX Index], including a capital loss of Rs101 and dividend reinvested of Rs6.

RECENT ALERTS

CLOSING UPDATE: Sun Pharmaceutical Industries decreases further 0.5% - underperforming 82% of stocks

15 January 2018 17:17 IST

Sun Pharmaceutical Industries, India's largest pharmaceuticals company by market capitalisation, has decreased Rs7.0 (or 1.2%) today to trade at Rs576.45 and has underperformed 82% of the market in the past one year. The present value of Rs1,000 invested one year ago is Rs895 [vs Rs1,279 for the BSE SENSEX Index], including a capital loss of Rs111 and dividend reinvested of Rs6. Compared with the BSE SENSEX Index which rose 251.1 points (or 0.7%) in the day, this represented a relative price change of -1.9%.

Afternoon Alert: Sun Pharmaceutical Industries decreases 0.8% - underperforming 88% of stocks

15 January 2018 12:59 IST

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) has decreased Rs4.40 (or 0.8%) today to trade at Rs579.05 and has underperformed 88% of the market in the past one year. The present value of Rs1,000 invested one year ago is Rs899 [vs Rs1,281 for the BSE SENSEX Index], including a capital loss of Rs107 and dividend reinvested of Rs6.

Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA; BSE:SUNPHARMA; NS:SUNPHARMA; IN:SUNPHARMA)

ISIN: INE044A01036

PermID: 4295873594

Source: www.BuySellSignals.com